Igen BioLab SL

📍 Madrid, Spain👥 9 employees💰 Last funded May 2020
Biotechnology Research🌐 igenbiotechgroup.com
Website LinkedIn
IGEN BIOTECH GROUP is working in new approaches to Medicine, discovering a variety of biological activities from vegetal and animal sources, which entail a major potential in terms of therapy and preventive diagnosis. IGEN BIOLAB, as part of Igen Biotech Group works on the specific development of a functional protein profile for oncological and degenerative diseases. IGEN BIOLAB specializes in protein production, bacterial characterization and development of manufacturing processes that are optimized for robust high scale up production. Our R&D facilities include technical areas of In vitro cultivation and testing of microorganisms, mass spectrometry-based proteomics technologies to identify, characterize and quantify target proteins in various biological and biomedical samples, metabolomics for detection and quantification of small molecules (metabolites) in biological materials, microbiomics focusing on using molecular DNA microarray technology to address the complexities of human infections and environmental microbiome ecology. Our commitment is to develop functional protein immunotherapies that help physicians and other healthcare professionals to provide high quality medical nutrition care and to improve patients’ quality of life.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Spain
1
Frequently asked questions
Who invested in Igen BioLab SL?
Igen BioLab SL has 1 investors on record on gritt.io.
When did Igen BioLab SL last raise funding?
The most recent investment in Igen BioLab SL recorded on gritt.io was in May 2020.
What industry is Igen BioLab SL in?
Igen BioLab SL operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Igen BioLab SL based?
Igen BioLab SL is headquartered in Madrid, Spain.